Skip to main
IRTC

iRhythm Technologies (IRTC) Stock Forecast & Price Target

iRhythm Technologies (IRTC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 46%
Buy 38%
Hold 15%
Sell 0%
Strong Sell 0%

Bulls say

iRhythm Technologies has raised its 2025 revenue guidance to $735M-$740M, representing a robust 24.6% year-over-year growth at the midpoint, reflecting strong demand for its innovative cardiac monitoring solutions. The company achieved an adjusted gross margin of 71.1%, exceeding consensus estimates and demonstrating improved operational efficiency. Additionally, iRhythm is experiencing significant international expansion, with systems operational in Japan and ongoing growth in the UK private market, further underpinning its positive financial outlook.

Bears say

The financial outlook for iRhythm Technologies Inc. remains negative due to several identifiable risks, including a slowdown in growth to the low-teens and challenges in reaching profitability as indicated by the company's history of net losses. Furthermore, regulatory uncertainties stemming from a DOJ inquiry and FDA warning, combined with a highly competitive market and the potential for negative reimbursement developments, pose significant threats to its revenue prospects. Compounding these concerns are operational risks, including possible disruptions in sales execution and the necessity for restructuring in response to changes in the regulatory environment.

iRhythm Technologies (IRTC) has been analyzed by 13 analysts, with a consensus rating of Buy. 46% of analysts recommend a Strong Buy, 38% recommend Buy, 15% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About iRhythm Technologies (IRTC) Forecast

Analysts have given iRhythm Technologies (IRTC) a Buy based on their latest research and market trends.

According to 13 analysts, iRhythm Technologies (IRTC) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $205.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $205.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

iRhythm Technologies (IRTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.